Navigation Links
Amgen To Provide Testimony At FDA Stakeholder Hearing On Biosimilars
Date:5/11/2012

THOUSAND OAKS, Calif., May 11, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) announced today that Joseph P. Miletich, M.D., Ph.D., senior vice president of Research and Development at Amgen will testify at the United States (U.S.) Food and Drug Administration (FDA) stakeholder hearing on biosimilars. Miletich will urge members of the FDA panel charged with implementing a pathway for biosimilars to establish approval standards that advance patient safety and promote confidence in biosimilars marketed in the U.S.

In his opening remarks, Miletich will underscore the wealth of experience Amgen brings to the discussion on biosimilars approval pathway implementation. "As a leading provider of high quality biologic medicines, Amgen appreciates the challenges of developing and manufacturing innovative and biosimilar medicines."

"Put patients first and sound policy will follow," Miletich states.  "Amgen appreciates the FDA's efforts on the guidelines and encourages adoption of a thorough review and approval process. However, Amgen believes some changes and additional clarity are needed."

Noting the complexities of biological products and the potential differences in products created from different living cells, Miletich will emphasize that biotechnology is an evolving field.  "While much more is known today than 30 years ago, FDA's guidance documents should candidly acknowledge that there are some things we still do not scientifically know today," says Miletich.

Miletich will state that "patient safety must be a non-negotiable priority for FDA and manufacturers, and that focus on patient safety does not end with drug approval."  He will outline three key recommendations that the FDA should consider as it finalizes its guidances:  

  1. Adopt policies to facilitate attribution of adverse events and
    '/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amgen to Present at the Baird Growth Stock Conference
2. Four Californians Selected As Breakaway from CancerĀ® Champions To Be Honored During Amgen Tour of California
3. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
4. Amgen Announces Webcast of 2012 First Quarter Financial Results
5. UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
6. Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc.
7. Schwartz Center Receives $500,000 Grant from the Amgen Foundation
8. Amgen to Present at the Cowen and Company 32nd Annual Healthcare Conference
9. Amgen and Micromet Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Micromet
10. Amgens Full Year 2011 Revenue Increased 4 Percent to $15.6 Billion and Adjusted Earnings Per Share (EPS) Increased 2 Percent to $5.33
11. Amgen Announces Final Results of Its Tender Offer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... 2, 2014  InfinityQS International, Inc., the global ... announces key client speakers for Infusion Chicago, its ... The event will be held Oct. 9-10, 2014, ... include projects from Coloplast, The Kellogg Company, Biomet, ... King. The two-day event will also include best ...
(Date:10/2/2014)... , Oct. 2, 2014   Softworld, Inc. announced ... new practice solely focused on the specific needs of ... While Softworld has already been highly successful in the ... additional capabilities to support the quality, regulatory, and validation ... now a combination of the current Biometric team and ...
(Date:10/2/2014)... Oct. 2, 2014   West Pharmaceutical Services, Inc. ... in innovative solutions for injectable drug administration, announced today ... include a new site in Waterford, Ireland ... for insulin injector cartridges and other high-value packaging components, ... biotech customers. Once operational, this new site could bring ...
Breaking Medicine Technology:InfinityQS Infusion Chicago to Spotlight Manufacturers' Key Successes in Achieving Enterprise Quality 2InfinityQS Infusion Chicago to Spotlight Manufacturers' Key Successes in Achieving Enterprise Quality 3Softworld, Inc. Launches Strategic Division Dedicated to Life Sciences Consulting 2West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 2West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 3West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 4West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland 5
... Jan. 12, 2011 Webmedx , the third largest ... provider in the U.S., today announced it has received the ... the 2010 Top 20 Best in KLAS Awards: Software ... Best in KLAS 2010 award, the company was also rated ...
... 2011 RESMED INC. (NYSE: RMD ), announced ... its results for the second quarter and six months of ... with ResMed,s results will be issued after 1:00 p.m. pacific ... webcast to review its results, market trends, and future outlook. ...
Cached Medicine Technology:Webmedx Named Best in KLAS and Ranked #1 Transcription Services Vendor for Second Year in a Row 2Webmedx Named Best in KLAS and Ranked #1 Transcription Services Vendor for Second Year in a Row 3ResMed Announces Conference Call and Webcast to Discuss Second Quarter 2011 Results 2
(Date:10/2/2014)... Dennis Thompson HealthDay Reporter ... newborn,s risk of developing celiac disease isn,t reduced by breast-feeding. ... wheat called gluten to an infant,s diet help prevent celiac ... of new studies in the Oct. 2 New England ... rest hopes that a child could avoid celiac disease if ...
(Date:10/2/2014)... Dennis Thompson HealthDay Reporter ... and the District of Columbia now have a total of ... that has been infecting children since the summer, U.S. ... virus have died in recent weeks, but it,s not clear ... those deaths, officials said. Health officials are also trying ...
(Date:10/1/2014)... small protein beta-amyloid is strongly associated with Alzheimer,s disease; ... this peptide is the causal agent of the onset ... such confirmation is that beta-amyloid is not harmful when ... is when it self-assembles to form the so-called amyloid ... target, beta-amyloid alone, but with multiple ones because each ...
(Date:10/1/2014)... Computer modelling of the human eye, the brain of ... neuroscience and new technology, says a QUT leading robotics ... and Engineering Faculty says the new study uses new ... by high-density buildings or tunnels. , "This is a ... "It,s putting two halves of a thing together because ...
(Date:10/1/2014)... 1, 2014) Despite a policy focus on ... disabilities, this vulnerable population continues to have significant ... The Journal of the American Dental Association , ... Tufts University School of Dental Medicine report on ... at-home oral care provided by caregivers to adults ...
Breaking Medicine News(10 mins):Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 2Health News:Infant's Early Diet Doesn't Change Celiac Disease Risk, Study Finds 3Health News:42 States Reporting Respiratory Virus That Targets Kids 2Health News:42 States Reporting Respiratory Virus That Targets Kids 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2Health News:Robot researcher combines nature to nurture 'superhuman' navigation 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3
... April 1 Edifecs announced ... implementation issues that providers, payers, clearinghouses and other healthcare ... new standards. In these sessions, Edifecs will offer ... Edifecs5010(TM) Migration -- a comprehensive set of products, online ...
... climate change and semi-arid regions turn to desert, people ... to be displaced. A mathematical approach to planned relocation ... Operational Research . , Decision scientist Sajjad Zahir at ... Sarker of the University of New South Wales, Canberra, ...
... Stem Cell Biotherapy ("SCB") announced that it filed ... against the Company,s Co-Founder and former President Casey Nabavi ... Nabavi giving rise to patient claims against Nabavi that ... medicine without a license, supervised the injection of stem ...
... the Nation,s Largest Independent Online Retailer of Beauty ... YORK, March 24 Sandow Media, parent company ... site SpaLook.com, and Salu Beauty, parent company of ... scale and reach for beauty product manufacturers. This ...
... is National STD Awareness Month , HARRISBURG, Pa., April ... of the continuing need for men and women to ... diseases, or STDs, as well as the importance of ... providers. "Although many STDs are treatable, screening and early ...
... Innovations, Inc. (NYSE: IMA ), a global leader ... home through the merger of rapid diagnostics and health management, ... elected to the company,s board of directors. Dr. Adashi, a ... and in the Life Sciences was also appointed to serve ...
Cached Medicine News:Health News:Edifecs Launches First of a Series of Edifecs5010(TM) Migration Educational Webinars Addressing 5010 Migration Challenges, Opportunities and Solutions 2Health News:Edifecs Launches First of a Series of Edifecs5010(TM) Migration Educational Webinars Addressing 5010 Migration Challenges, Opportunities and Solutions 3Health News:Relocation, relocation, relocation 2Health News:Stem Cell Biotherapy Sues Casey Nabavi, Co-Founder and Former President, for Conduct Resulting in Claims by SCB Patients Against Nabavi, Embezzling Money and Converting Other Assets Belonging to SCB and for Wrongfully Establishing Cellulogix Biosciences t 2Health News:NewBeauty Magazine and SpaLook.com Create Strategic Alliance With Salu Beauty and SkinStore.com 2Health News:NewBeauty Magazine and SpaLook.com Create Strategic Alliance With Salu Beauty and SkinStore.com 3Health News:Pennsylvania Department of Health Urges Greater Awareness of, Testing for Sexually Transmitted Diseases 2Health News:Eli Y. Adashi, MD, MS, FACOG, Joins Inverness Medical Innovations' Board of Directors 2
... circulating testosterone exists as unbound or free ... to SHBG with high affinity [1], while ... Both the albumin-bound and free fractions may ... testosterone action. Measurement of the free or ...
... active hormone synthesized within the follicular cells ... synthesized via a series of steps involving: ... (ii) iodination of tyrosine residues in the ... and 3,5-diiodotyrosine (MIT and DIT), and (iii) ...
... factor binding protein-3 (IGFBP-3) is the main binding ... as a component of the ~150 kDa ternary ... of IGF-I or IGF-II and ALS, allowing IGFBP-3, ... the IGFs. The molar concentration of IGFBP-3 in ...
... (GH) is a monomeric protein produced and ... gland. GH is released from the pituitary ... under the regulatory control of hypothalamic somatostatin ... timing and frequency of GH release appears ...
Medicine Products: